Philadelphia-like (Ph-like) B-ALL, characterized by a gene expression profile similar to Ph+ B-ALL but lacking the BCR-ABL1 fusion, occurs in 10–15% of pediatric and up to 30% of adult cases, and is associated with poor prognosis, chemotherapy resistance, and frequent IKZF1 deletions. Here, ABL1 is linked to acute lymphoblastic leukemia.